issue
distinguished
taken
london
pyrimeth
potentially
rarely
malar
address
1322
rbm
mild
ensures
project
death
ications
characterized
headache
appropriate
rate
dramatically
ran
outcome
chlo
lack
even
immediately
acceptance
final
kilian
square
756
bility
meshnick
542
aetiology
yeka4
vis
neurological
physicians
references
set
mubende
tial
white
capture
coordination
sion
driven
both
1950
ments
tw01506
dihydroartemisi
hae
object
181
tree
disease
ence
increas
age
higher
1655
tests
results
antimalarial
njama
tem
four
reachbridget
tained
confounder
recommendations
affected
experience
individual
atalisuna
routine
laboratories
365
multivariate
studies
408
chloroquine
action
causal
widespread
act
exact
college
lacking
168
124
selecting
identified
sig
description
populations
gmail
series
combination
talisuna
assignments
md
regimen
antimalar
original
increase
providing
doi
2001
published
tive
months
widely
trine
past
aes
toring
under
nsobya
lacked
incapacity
toxicity
accepted
dan
medical
192
vomiting
theory
pilot
failures
without
fever
gikunda
department
plicated
tional
follow
continued
longitudinal
199
resistance
methodology
labora
practice
order
ich
definitely
dfid
babiker
131
pjr
back
as
belgium
repeat
variables
assessment
child
dermatologic
org
worsening
limitations
finger
cited
your
bone
logis
accordingly
differ
371
resulted
criteria
reflects
9449
613
compared
ashley
did
relationship
any
more
patterns
report
analyse
demonstrate
col
248
venture
problematic
phar
898
finan
bination
measurement
gdorsey
relevant
part
540
seen
drug
only
jama
193
lished
fal
seven
good
dependent
screen
systematic
roll
associated
duke
come
file
preparation
least
less
depending
u50
laboration
tionship
2210
biomedcentral
died
affiliations
science
mr
anti
biopsy
august
incentive
some
committee
unrestricted
faucher
tant
fails
aquine
tolerability
improve
aspect
detected
e190
endemic
analysing
variation
multicentre
intense
cent
creative
385
clark3
enrolment
randomization
parasitol
award
loolpapit
lower
diarrhoea
specific
design
underestimate
ideally
interests
occurred
pj
licenses
prosenthal
tries
ranging
entered
policies
guide
choice
increasingly
preventing
dorsey
institutes
newer
297
olliaro
pancytopaenia
followed
tings
scales
coun
neurologic
barnes
sys
mittee
cohort
hospital
at
ideal
causally
figure
being
cds
december
rela
clini
moder
drugman
http
may
medicinal
archived
different
sg
int
number
ea
adjuik
organization
mpimbaza
population
test
how
event
yeka
lumefan
question
tanzanian
elimination
ciated
also
related
geographic
ranged
harvard
gitudinal
acknowledged
include
develops
cies
papers
126
2875
hasifa
limiting
176
banek
comparisons
adoke
illustrates
ures
pain
page
sam
artekin
discussed
mendations
june
assessed
time
human
489
evaluating
cal
complex
cell
has
2007
isuna
unpublished
103
labo
yadoke
useful
grant
143
dif
consortium
effi
until
slater
uncomplicated
pharmacodynamic
box
therapy
con
charge
randomized
personnel
observed
1348
agnamey
1475
perform
range
cial
133
particularly
effect
transmission
administering
falci
help
email
e20
recurrent
access
confer
kironde
urban
thank
definite
supported
there
gd
mended
180
examina
pharma
hopkins
certain
yau
anemia
organiza
nzarubara5
designing
authors
1london
african
should
allocating
parum
rwagacondo
ity
interest
therapies
men
clinical
properly
recipient
pharmacovigi
treating
confound
additional
187
visits
212
biomedical
reporting
bakyaita
result
findings
fanello
per
performed
center
physical
9469
power
important
samples
175
lance
all
arua
total
mendis
development
submit
control
including
surgical
wr
complete
1957
554
pants
artemisinin
bm
uation
karema
altered
tclark
multiple
ministry
chosen
methods
modelled
duration
reingold
writing
banek4
details
529
significant
coryza
aminotransferase
designed
post
comes
cacy
adverse
plos
1159
classification
alternative
effects
life
malnutri
km
symptoms
chi
entomological
palacios
greenwood
every
national
policy
algorithms
addressed
s2
permits
s1932
highly
bukirwa
study
yahoo
arm
affect
2287
about
defined
ened
amine
jp
threaten
technical
congenital
mulago
monitoring
station
omized
allen
hypothesis
resolved
premji
blinding
severity
amodi
collection
pyrimethamine
991
revealed
ease
large
attempt
treatment
hyg
initial
apac
ent
consolidated
category
central
dihydroartemisinin
tion
ciparum
aware
varia
lead
baseline
capturing
council
heart
2005
drakeley
jb
sulphadoxine
versus
disability
examinations
reported
randomised
mined
e6
sodes
tdc
whether
guidance
harmonization
hearing
was
role
assess
experi
tropical
countries
half
jinja
available
revising
protocols
however
double
patients
subk0001
mission
brief
nausea
decision
396
allowed
site
laboratory
standardized
considered
threatening
ies
approval
objective
still
pg
will
parasitaemia
reluctance
captured
ccu925122
cause
neurotoxicity
associations
tar
160
component
became
nosten
480
107
brasseur
221
cence
417
then
cols
muucsf
talisuna7
meso
blood
recrudes
weeks
dihy
analyzing
increased
frequent
six
macovigilance
food
intensity
kemble
thus
restricted
similar
difficulty
combine
nations
same
standardize
license
timing
182
here
167
given
moni
sebuguzi5
130
article
ous
symptom
peer
determining
corporation
province
clin
acute
anaemia
profiles
www
diseases
children
problems
cooperative
stata
characteristics
geneva
single
endemicity
herbal
ing
fisher's
fred
scheduled
522
rwanda
limited
within
obtained
toe
abdominal
generate
response
1736
lon
infections
transmis
1955
jf
broad
vary
umsp
bk
used
when
responsible
background
vm
wors
conduct
unscheduled
developing
randomly
untoward
institute
initially
1365
administration
ial
4uganda
aq
asso
small
lell
sgs
limits
197
click
1111
repeated
cj
ugan
marrow
training
low
while
developed
coosemans
purposes
pe
fell
589
150
persistent
decreased
rockville
jagannathan
ate
d'alessandro
guardians
rwakimari
uncom
either
detect
throughout
lshtm
hypotheses
restrict
concerns
1057
162
defect
al
inoculation
size
estimates
publish
side
910
balance
matsiegui
lines
safety
497
chance
majority
190
commit
epi
protocol
ethical
asp
172
sl
highest
reproduction
fwabwire
severe
team
anthony
requests
sub
2003
categorical
pooling
medicine
shown
excluded
350
contributions
2002
regi
conducting
giving
tables
importance
bukirwa4
treated
local
cmaiteki
573
ltd
understandable
challenges
ance
artemether
serious
keep
episode
tororo
outpatient
yours
mrk
ao
htm
2081
diversity
diagnosed
drugs
doc
falade
sd
uncommon
kb
table
ruling
359
225
substantial
burden
could
128
missed
rates
port
passive
research
considering
exclud
procedures
icy
disseminating
licensee
decisions
geertruyden
trop
prior
convulsions
fered
would
adapted
persisted
significantly
global
adopted
consistency
submission
durrheim
eph
planning
nificant
sk
approach
efficacy
downgrade
grateful
rather
agen
volume
difficulties
132
mental
van
key
likelihood
whitty
998
appear
alanine
diar
pediatrics
exist
piperaquine
funding
doris
344
tk
davis
entire
who
tireless
previously
simple
missinou
149
increases
failure
factors
commonly
expected
3117
pi
many
580
author
382
supporting
causality
comments
classifying
178
san
focusing
patient
illnesses
presented
andriano
account
alone
parameter
relation
combina
beyond
nonartemisi
score
soc
cough
possible
later
bosman
members
length
cokinetic
cost
ric
introduced
excluding
hygiene
gathering
withdrawn
our
its
deploying
typically
group
vanb
dp
543
supplementary
classified
than
deter
just
effective
technology
effort
suspected
stud
bio
following
data
after
amodiaquine
rezbach
challenged
difference
cific
roelants
mkamya
lugemwa
kamya
866
medications
new
evaluation
k23
reviewed
needed
exam
conclusion
variable
hy
occurrence
meya
haemoglobin
generally
changed
mehta
antwerp
1105
predictors
denise
respiratory
ten
hbukirwa
material
karbwang
groups
detailed
most
greenhouse
had
information
parative
6makerere
concomi
survived
assessing
lifetime
upon
prescribed
multisite
biomed
publishing_adv
anorexia
malarial
presumed
into
advanced
438
overlap
tal
probably
uganda
400
analysis
1372
received
kampala
sarah
cooperation
industry
okello
ntoumi
centralized
adults
sophisticated
viral
applied
function
mu
financial
non
peri
bridget
focus
adherence
ability
infectious
likely
prasanna
illustrated
philip
recom
com
chloro
mwanza
858
makerere
thrombocytopaenia
geted
saharan
602
other
parents
bn
fication
allocation
university
transfusion
another
1474
makanga
s1
2008
ship
ticularly
csr
clinically
032
hypoplastic
washington
artemisinins
pharmacovigilance
reports
infocom
graded
well
potential
none
pool
acts
establishing
subjective
weakness
world
ce
greatest
early
eval
ers
196
nal
kanungu
prick
194
ai43301
undetermined
2160
various
pubmed
copyright
july
possibly
rhoea
worsened
terms
definitions
364
census
spe
examination
uncompli
attempted
541
lumefantrine
comparative
dorsey2
artemisi
resist
kindly
100
their
scale
nurse
sa3569
included
interpretation
171
required
smears
distribution
cancer
but
557
over
agreement
prevent
ucsf
tamara
collect
citation
evaluations
fund
unlikely
evidence
jc
500
sir
based
assigned
rural
roquine
kamya5
made
priority
hospitalization
such
greater
coinciding
cber
successfully
wabwire
elevated
evaluate
ment
routinely
individually
osimbo
ai49212
arthur
encing
dexterity
international
assessments
proto
nzarubara
kristin
days
mpumalanga
cms
identifying
use
despite
confounded
384
approaches
temperature
doren
staedke
conference
moglobin
events
safe
nin
subsequently
establish
mean
began
surveillance
1120
edu
tory
np
medium
tolerated
1828
mond
166
abstract
major
acknowledgements
partici
cder
rand
185
thin
sp
ki
127
administra
trans
recruitment
participant
previous
101
recurred
presence
jagannathan3
regardless
faced
south
measuring
falciparum
info
medsfgh
amount
mabuza
vari
116
systematically
few
001
researc
domised
intervals
selected
applying
fine
pol
products
pharmaceuticals
hallett
treatments
blumberg
pb
known
differences
merging
relying
biologics
line
longitudi
registration
quine
7475
ay
plus
need
meya5
young
trials
microbiology
gcp
conflicts
period
although
pediat
microsoft
2006
systems
red
welcomed
coartem
ences
support
1462
unless
february
content
malaria
oratory
schools
probable
rosenthal
coopera
recently
saf
moses
revised
classes
fogarty
distributed
sus
saes
1186
attribution
open
ataxia
participated
u01a1052142
encounter
alternatively
demonstrating
pooled
efficacious
they
definition
diagnosis
garner
kebanek
experiencing
cycle
defining
ini
pick
consisting
421
cq
receiving
berkeley
excellent
1480
median
extend
subject
system
enrolled
model
tic
ma
876
addition
charitable
sulfadoxine
risk
mpimbaza5
clark
outcomes
california
case
deaths
effectively
confounding
sites
120
taylor
overmeir
pow
1129
continuous
episodes
extra
byaruhanga
varied
yield
variability
active
arthurwakg
thick
impact
raising
currently
med
conceived
catherine
signs
provided
2219
kyenjojo
322
mangen
talemwa
commons
nystagmus
hunt
nate
suppl
become
presentation
history
ahmed
consideration
classi
careful
several
899
simplify
ple
might
informing
treat
par
corresponding
discussion
alt
challenging
moderate
collaboration
diallo
insensitive
174
work
musph
conducted
three
harmonisation
464
specifically
sever
7ministry
two
each
count
africa
controlling
106
pant
audiometric
participants
borrmann
596
deployment
recognized
limit
238
approved
5makerere
detecting
testing
ered
one
ferences
631
usa
146
neutropaenia
proportion
addressing
heel
medicines
practices
1660
sample
very
infection
status
problem
sebuguzi
tw00007
impor
pos
journal
highlighted
exami
1622
ci
due
regression
534
guided
collected
ambrose
sponsors
etiologies
adoption
tx
often
unrelated
creativecommons
sr
francisco
evaluated
areas
aot
described
relationships
free
rwandan
congestive
sent
transition
lancet
addi
zion
aged
614
droartemisinin
between
fail
424
dose
trial
td
controlled
am
public
pattern
day
eleven
scientist
illness
using
interpreting
since
3department
reactions
critical
1996
ethics
ever
878
artesu
appeared
compare
imens
sensitiv
properties
mutabingwa
nj
manuscript
plasmodium
ferent
declare
2004
level
concomitant
173
spleen
uk
abnormalities
complicated
guidelines
219
slightly
ngamije
cobelens
optimal
ugandan
myint
ratory
rosenthal3
lab
challenge
nurses
heidi
further
kremsner
november
summary
reg
mueller
sev
step
286
krishna
capacity
eral
9315
hb
000
diagnostic
analytical
therapeutic
found
association
grading
sup
romberg
palpable
correwyn
iqr
across
tle
maiteki
paul
screening
minimize
1108
irrespective
school
1994
estab
read
once
mangen6
332
present
dokomajilar
intervention
analysed
susceptibility
292
creatinine
version
common
health
prospectively
sibly
comparing
general
maximum
mechanisms
five
regimens
artesunate
cated
521
out
seem
simooya
categories
ure
requires
551
heller
require
lessons
noted
malariajournal
not
years
277
foundation
effectiveness
pruritus
division
informed
selection
services
standard
community
cisse
403
high
availability
fwm
first
dnm